In-Hospital Management and Long-term Clinical Outcomes and Adherence in Patients With Acute Decompensated Heart Failure: Primary Results of the First Brazilian Registry of Heart Failure (BREATHE).

BACKGROUND: Heart failure (HF), a common cause of hospitalization, is associated with poor short-term clinical outcomes. Little is known about the long-term prognoses of patients with HF in Latin America. METHODS: BREATHE was the first nationwide prospective observational study in Brazil that included patients hospitalized due to acute heart failure (HF). Patients were included during 2 time periods: February 2011-December 2012 and June 2016-July 2018 SUGGESTION FOR REPHRASING: In-hospital management, 12-month clinical outcomes and adherence to evidence-based therapies were evaluated. RESULTS: A total of 3013 patients were enrolled at 71 centers in Brazil. At hospital admission, 83.8% had clear signs of pulmonary congestion. The main cause of decompensation was poor adherence to HF medications (27.8%). Among patients with reduced ejection fraction, concomitant use of beta-blockers, renin-angiotensin-aldosterone inhibitors and spironolactone decreased from 44.5% at hospital discharge to 35.2% at 3 months. The cumulative incidence of mortality at 12 months was 27.7%, with 24.3% readmission at 90 days and 44.4% at 12 months. CONCLUSIONS: In this large national prospective registry of patients hospitalized with acute HF, rates of mortality and readmission were higher than those reported globally. Poor adherence to evidence-based therapies was common at hospital discharge and at 12 months of follow-up.

Depression and Cardiovascular Disease in Women

Abstract The prevalence of depression varies from 1 to 17% in different geographic regions, and its incidence is 70% higher in women than men. Today, depression affects more than 300 million people worldwide, affecting twice as many women from adolescence to adulthood. In addition to this earlier onset, depression in women tends to be more severe. Cardiovascular disease and depression are chronic diseases that have a major impact on cardiovascular and all-cause morbidity and mortality, with evidence of a two-way relationship between them, in which depression is a predictor of cardiovascular disease and vice versa. In females, the degree of illness and prognosis are more severe when both diseases are present, than when diagnosed alone. In patients with acute or chronic cardiovascular disease, especially women, a systematic screening for depression should be considered as a preventive strategy of cardiovascular events, aiming to reduce the risk of future events. There are still no clinical studies designed to assess the impact of antidepressant treatment on cardiovascular outcomes in women.

The REBECGA brazilian registry of pregnancy and heart disease: rationale and design

BACKGROUND: Maternal mortality rates in Brazil remain above the goals established by the United Nations Sustainable Development Goals. Heart disease is estimated to affect 4% of all pregnancies and remains by itself the main indirect obstetric cause of maternal death. In the last decades, a significant improvement in the prognosis of heart diseases has made pregnancy possible in women with heart disease and provided better maternal and fetal outcomes. OBJECTIVES: To establish a multicenter Brazilian Registry of pregnant women with heart disease; to study the causes of immediate and late maternal mortality; and to assess the prevalence of heart disease in the country's macro-regions. METHODS: This is an observational study, with retrospective and prospective stages, of the clinical and obstetric progression of pregnant women with heart disease. These women consecutively received care during pregnancy and will be followed up for up to a year after delivery at public and private hospitals with infrastructure for the execution of this project, a principal investigator, and approval by Ethics and Research Committees. RESULTS: Our results will be presented after data collection and statistical analysis, aiming to demonstrate immediate and late maternal mortality rates, as well as the prevalence of heart disease in the country and its cardiovascular and obstetric complications during pregnancy. CONCLUSIONS: REBECGA will be the Brazilian Registry of heart disease and pregnancy and it will contribute to planning preventive measures, raising financial resources for the improvement of high-risk prenatal care, and reducing immediate and late maternal mortality due to heart disease.

Efeitos cardíacos agudos da pré-eclâmpsia grave / Acute cardiac effects of severe pre-eclampsia

Introdução: A pré-eclâmpsia com características graves (PECG) é uma síndrome específica da gravidez caracterizada por hipertensão grave e disfunção de órgãos-alvo e está associada a eventos cardiovasculares adversos a curto prazo, incluindo insuficiência cardíaca, edema pulmonar e acidente vascular cerebral. Objetivos: Os autores tiveram como objetivo caracterizar as alterações ecocardiográficas, clínicas e laboratoriais de curto prazo em mulheres com PEC, concentrando-se na pressão sistólica do ventrículo direito (PSVD) e nos parâmetros diastólico, sistólico e de rastreamento diastólico, sistólico e de salpicos derivados do ecocardiograma. Métodos: Neste estudo observacional prospectivo, os autores recrutaram 63 mulheres com PEC e 36 pacientes controle grávidas. Resultados: A coorte PEC apresentou maior PSVD (31,0 ± 7,9 mm Hg vs. 22,5 ± 6,1 mm Hg; p <0,001) e diminuição da tensão sistólica longitudinal global do VD (RVLSS) (19,6 ± 3,2% vs. 23,8 ± 2,9% [p < 0,0001]) quando comparado com a coorte controle. Para os parâmetros cardíacos do lado esquerdo, houve diferenças (p <0,001) na velocidade e 'septal mitral (9,6 ± 2,4 cm / s vs. 11,6 ± 1,9 cm / s), relação E / e' septal (10,8 ± 2,8 vs. 7,4 ± 1,6), tamanho da área atrial esquerda (20,1 ± 3,8 cm2 vs. 17,3 ± 2,9 cm2) e espessura da parede posterior e septal (mediana [intervalo interquartil]: 1,0 cm [0,9 a 1,1 cm] vs. 0,8 cm [0,7 a 0,9 cm] e 1,0 cm [0,8 a 1,2 cm] vs. 0,8 cm [0,7 a 0,9 cm]). Oito mulheres (12,7%) com PEC apresentaram disfunção diastólica grau II e 6 mulheres (9,5%) apresentaram edema pulmonar periparto. Conclusões: Mulheres com PEC apresentam maior PSVD, maiores taxas de função diastólica anormal, menor RVLSS global, maior remodelamento da câmara do lado esquerdo e maiores taxas de edema pulmonar periparto, quando comparadas a mulheres grávidas saudáveis.

Introduction: Pre-eclampsia with severe features (PEC) is a pregnancy-specific syndrome characterized by severe hypertension and end-organ dysfunction, and is associated with short-term adverse cardiovascular events, including heart failure, pulmonary edema, and stroke. Objectives: The authors aimed to characterize the short-term echocardiographic, clinical, and laboratory changes in women with PEC, focusing on right ventricular (RV) systolic pressure (RVSP) and echocardiographic-derived diastolic, systolic, and speckle tracking parameters. Methods: In this prospective observational study, the authors recruited 63 women with PEC and 36 pregnant control patients. Results: The PEC cohort had higher RVSP (31.0 ± 7.9 mm Hg vs. 22.5 ± 6.1 mm Hg; p < 0.001) and decreased global RV longitudinal systolic strain (RVLSS) (19.6 ± 3.2% vs. 23.8 ± 2.9% [p < 0.0001]) when compared with the control cohort. For left-sided cardiac parameters, there were differences (p < 0.001) in mitral septal e' velocity (9.6 ± 2.4 cm/s vs. 11.6 ± 1.9 cm/s), septal E/e' ratio (10.8 ± 2.8 vs. 7.4 ± 1.6), left atrial area size (20.1 ± 3.8 cm2 vs. 17.3 ± 2.9 cm2 ), and posterior and septal wall thickness (median [interquartile range]: 1.0 cm [0.9 to 1.1 cm] vs. 0.8 cm [0.7 to 0.9 cm], and 1.0 cm [0.8 to 1.2 cm] vs. 0.8 cm [0.7 to 0.9 cm]). Eight women (12.7%) with PEC had grade II diastolic dysfunction, and 6 women (9.5%) had peripartum pulmonary edema. Conclusions: Women with PEC have higher RVSP, higher rates of abnormal diastolic function, decreased global RVLSS, increased left-sided chamber remodeling, and higher rates of peripartum pulmonary edema, when compared with healthy pregnant women. (J Am Coll Cardiol 2018;72:1­11) © 2018 by the American College of Cardiology Foundation.